000 01204 a2200361 4500
005 20250512085323.0
264 0 _c19860103
008 198601s 0 0 eng d
022 _a0167-6997
024 7 _a10.1007/BF00179435
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEarhart, R H
245 0 0 _aPhase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.
_h[electronic resource]
260 _bInvestigational new drugs
_c1985
300 _a297-301 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNitrosourea Compounds
_xadverse effects
650 0 4 _aTime Factors
700 1 _aMuggia, F M
700 1 _aGolomb, F M
773 0 _tInvestigational new drugs
_gvol. 3
_gno. 3
_gp. 297-301
856 4 0 _uhttps://doi.org/10.1007/BF00179435
_zAvailable from publisher's website
999 _c4071908
_d4071908